ASCEND CSP IDE Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 414 participants.
Also called NCT06830746
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 414 participants
- Sponsor
- Registry
-
NCT06830746
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States, Australia, Canada, France, Hong Kong SAR China, India, Italy, Singapore, Spain, Switzerland
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06830746. Allocation not applicable; no masking; primary purpose treatment. Start 2025-04-11 (actual); primary completion 2026-01-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ASCEND CSP IDE Study
- Acronym
- ASCEND CSP IDE
- Condition
- Heart Failure
- Condition
- Ventricular Arrythmia
- Intervention (Device)
- LBBAP Implant with a CSP ICD Lead
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct06830746- Content hash
acf2512382b36fddcc86f1a9e3a4031c481373a12cebebbb8798b19d1761e2eb